2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients who received age-and sex-appropriate preventive screenings and wellness services.Continue reading “2025 #497 MIPS Measure Preventive Care and Wellness (Composite)”
CQMS Archive
2025 #496 MIPS Measure Cardiovascular Disease (CVD) Risk Assessment Measure – Proportion of Pregnant/Postpartum Patients that Receive CVD Risk Assessment with a Standardized Instrument
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of pregnant or postpartum patients who received a cardiovascular disease (CVD)Continue reading “2025 #496 MIPS Measure Cardiovascular Disease (CVD) Risk Assessment Measure – Proportion of Pregnant/Postpartum Patients that Receive CVD Risk Assessment with a Standardized Instrument”
2025 #495 MIPS Measure Ambulatory Palliative Care Patients’ Experience of Feeling Heard and Understood
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure (PRO-PM) – High Priority Description: The percentage of top-box responsesContinue reading “2025 #495 MIPS Measure Ambulatory Palliative Care Patients’ Experience of Feeling Heard and Understood”
2025 #493 MIPS Measure Adult Immunization Status
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients 19 years of age and older who are up-to-dateContinue reading “2025 #493 MIPS Measure Adult Immunization Status”
2025 #491 MIPS Measure Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of surgical pathology reports for primary colorectal, endometrial,Continue reading “2025 #491 MIPS Measure Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status”
2025 #490 MIPS Measure Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients, aged 18 years and older, with a diagnosis ofContinue reading “2025 #490 MIPS Measure Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors”
2025 #489 MIPS Measure Adult Kidney Disease: Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #489 MIPS Measure Adult Kidney Disease: Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy”
2025 #488 MIPS Measure Kidney Health Evaluation
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18-85 years with a diagnosis of diabetes whoContinue reading “2025 #488 MIPS Measure Kidney Health Evaluation”
2025 #487 MIPS Measure Screening for Social Drivers of Health
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percent of patients 18 years and older screened forContinue reading “2025 #487 MIPS Measure Screening for Social Drivers of Health”
2025 #486 MIPS Measure Dermatitis – Improvement in Patient-Reported Itch Severity
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-based Performance Measure – High Priority Description: The percentage of patients aged 8Continue reading “2025 #486 MIPS Measure Dermatitis – Improvement in Patient-Reported Itch Severity”